{"data":[{"accessionNo":"0001137774-26-000205","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common","eventDate":"2026-09-30","reportingPerson":"PRUDENTIAL FINANCIAL INC","reportingCik":null,"personType":"HC","sharesOwned":2231357,"percentOfClass":11.2,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0000053417-26-000058","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"NEUROGENE INC","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Jennison Associates LLC","reportingCik":null,"personType":"IA","sharesOwned":2229082,"percentOfClass":11.1,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-097193","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value","eventDate":"2026-06-30","reportingPerson":"Redmile Group, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1572202,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-097193","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value","eventDate":"2026-06-30","reportingPerson":"Jeremy C. Green","reportingCik":null,"personType":"HC,IN","sharesOwned":1572202,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001172661-26-003430","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":818706,"percentOfClass":5.18,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001172661-26-003430","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":818706,"percentOfClass":5.18,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001172661-26-003430","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BALYASNY ASSET MANAGEMENT L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":818706,"percentOfClass":5.18,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001172661-26-003430","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":818706,"percentOfClass":5.18,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001172661-26-003430","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":818706,"percentOfClass":5.18,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-097193","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value","eventDate":"2026-06-30","reportingPerson":"Redmile Biopharma Investments I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":812033,"percentOfClass":5.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-26-038383","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value per share","eventDate":"2026-06-30","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":714885,"percentOfClass":4.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-26-038383","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value per share","eventDate":"2026-06-30","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":714885,"percentOfClass":4.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-26-038383","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":"64135M105","securityClass":"Common Stock, $0.000001 par value per share","eventDate":"2026-06-30","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":714885,"percentOfClass":4.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-016440","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock, $0.000001 par value","eventDate":"2025-12-31","reportingPerson":"Redmile Group, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1557179,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-016440","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock, $0.000001 par value","eventDate":"2025-12-31","reportingPerson":"Jeremy C. Green","reportingCik":null,"personType":"HC,IN","sharesOwned":1557179,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001104659-26-016440","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock, $0.000001 par value","eventDate":"2025-12-31","reportingPerson":"Redmile Biopharma Investments I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":749610,"percentOfClass":4.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-25-027814","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-08","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":785000,"percentOfClass":5.1,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-25-027814","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-08","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":785000,"percentOfClass":5.1,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0001493152-25-027814","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-08","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":785000,"percentOfClass":5.1,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0000935836-25-000698","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1442902,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0000935836-25-000698","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":1442902,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"},{"accessionNo":"0000935836-25-000698","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404644","issuerName":"Neurogene Inc.","ticker":"NGNE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1249344,"percentOfClass":8.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ngne"}],"updatedAt":"2026-11-04T05:26:10.223Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ngne","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}